Description
Contents: 232 Kits – Each kit contains: Test device (2), Extraction vial (2), Cap (2), swabs (2), Quick Reference Instructions (QRI) (1)
Regulatory Status: FDA Emergency Use Authorization, OTC
Determinations: Detection of the SARS-CoV-2 nucleocapsid protein antigen
Processing Time: 10 Minutes
The CareStart™ COVID-19 Antigen Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2.
- Case quantity for Resale
- Fast and easy to self-test at anywhere
- Easy to interpret the results using mobile application
- Use for nasal swab specimen
- Identify individual’s current infection status to COVID-19
Product Resources:
